Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH IPCA LABS PANACEA BIOTECH/
IPCA LABS
 
P/E (TTM) x -62.3 51.8 - View Chart
P/BV x 0.9 5.4 16.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 PANACEA BIOTECH   IPCA LABS
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
IPCA LABS
Mar-23
PANACEA BIOTECH/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1911,062 18.0%   
Low Rs107768 14.0%   
Sales per share (Unadj.) Rs75.1243.0 30.9%  
Earnings per share (Unadj.) Rs-5.519.4 -28.4%  
Cash flow per share (Unadj.) Rs0.929.7 3.0%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs137.7230.3 59.8%  
Shares outstanding (eoy) m61.25253.70 24.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.03.8 52.8%   
Avg P/E ratio x-27.147.2 -57.4%  
P/CF ratio (eoy) x170.030.8 551.8%  
Price / Book Value ratio x1.14.0 27.3%  
Dividend payout %020.6 -0.0%   
Avg Mkt Cap Rs m9,142232,120 3.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,26512,876 9.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59961,642 7.5%  
Other income Rs m5171,518 34.0%   
Total revenues Rs m5,11663,160 8.1%   
Gross profit Rs m479,033 0.5%  
Depreciation Rs m3912,616 15.0%   
Interest Rs m44482 9.2%   
Profit before tax Rs m1287,453 1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4662,534 18.4%   
Profit after tax Rs m-3374,919 -6.9%  
Gross profit margin %1.014.7 7.0%  
Effective tax rate %363.534.0 1,069.4%   
Net profit margin %-7.38.0 -91.9%  
BALANCE SHEET DATA
Current assets Rs m5,62351,893 10.8%   
Current liabilities Rs m3,29718,058 18.3%   
Net working cap to sales %50.654.9 92.1%  
Current ratio x1.72.9 59.3%  
Inventory Days Days5951 114.6%  
Debtors Days Days486 814.3%  
Net fixed assets Rs m7,02834,336 20.5%   
Share capital Rs m61254 24.1%   
"Free" reserves Rs m8,37558,167 14.4%   
Net worth Rs m8,43658,420 14.4%   
Long term debt Rs m2026,518 3.1%   
Total assets Rs m12,71286,229 14.7%  
Interest coverage x3.916.5 23.6%   
Debt to equity ratio x00.1 21.4%  
Sales to assets ratio x0.40.7 50.6%   
Return on assets %-2.36.3 -36.8%  
Return on equity %-4.08.4 -47.5%  
Return on capital %2.012.2 16.3%  
Exports to sales %43.342.9 101.0%   
Imports to sales %24.413.3 184.2%   
Exports (fob) Rs m1,99226,434 7.5%   
Imports (cif) Rs m1,1248,178 13.7%   
Fx inflow Rs m1,99226,434 7.5%   
Fx outflow Rs m1,1918,178 14.6%   
Net fx Rs m80118,257 4.4%   
CASH FLOW
From Operations Rs m-4,2258,058 -52.4%  
From Investments Rs m4,303-7,250 -59.4%  
From Financial Activity Rs m-1845,072 -3.6%  
Net Cashflow Rs m-1055,881 -1.8%  

Share Holding

Indian Promoters % 73.6 46.3 159.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 44.8 2.1%  
FIIs % 0.3 10.3 2.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 53.7 49.2%  
Shareholders   47,091 82,809 56.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs IPCA Labs Share Price Performance

Period Panacea Biotech IPCA Labs S&P BSE HEALTHCARE
1-Day 0.45% 3.54% 1.21%
1-Month -18.23% 4.47% -0.72%
1-Year 14.23% 56.78% 61.87%
3-Year CAGR -11.62% 9.53% 18.17%
5-Year CAGR -9.58% 20.93% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.